Enhancing Oncolytic Adenovirus Replication by Early Region 1A Protein-Mediated Degradation of E1A Binding Protein

Boduan Xiao1, Qingzhe Yang1, Shichuan Hu1

  • 1Department of Biotherapy,Cancer Center and State Key Laboratory of Biotherapy West China Hospital Sichuan University Chengdu People's Republic of China.

Medcomm
|April 3, 2026
PubMed

Insights

Oncolytic adenovirus (OAd) therapy uses E1A to reduce p300 expression, enhancing viral replication and tumor cell killing. This mechanism offers a potential biomarker for OAd patient selection and novel cancer treatment strategies.

Area of Science:

  • Oncolytic virotherapy
  • Molecular oncology
  • Cancer immunology

Background:

  • Oncolytic adenovirus (OAd) is a promising cancer treatment, relying on viral replication.
  • Adenovirus E1A protein is crucial for viral replication.
  • Understanding E1A's regulatory role in OAd replication is vital for optimizing therapy.

Purpose of the Study:

  • To investigate the mechanism by which E1A regulates OAd replication.
  • To explore the interaction between E1A and the p300 protein.
  • To evaluate the therapeutic potential of enhancing OAd activity through p300 modulation.

Main Methods:

  • Western blot to detect p300 and E1A expression.
  • Virus replication assays to quantify OAd replication.
  • Immunofluorescence and immunoprecipitation to analyze E1A-p300 interaction.
  • MTT assays and animal experiments to assess therapeutic efficacy.

Main Results:

  • OAd infection or E1A overexpression reduced p300 expression.
  • p300 knockdown enhanced OAd viral replication and cancer cell cytotoxicity.
  • E1A promoted OAd replication by mediating p300 ubiquitination and inhibiting the IFI16/STING/IRF3/IFN-β pathway.
  • OAd engineered to knockdown p300 (OAd-shp300) showed enhanced replication and potent antitumor activity in vitro and in vivo.

Conclusions:

  • OAd utilizes E1A to promote p300 ubiquitination and degradation, enhancing viral replication and cytotoxicity.
  • This mechanism provides a potential biomarker for identifying patients responsive to OAd therapy.
  • Targeting p300 offers a novel strategy for improving clinical outcomes in OAd cancer treatment.

Related Concept Videos

Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.5K
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.9K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.2K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

3.1K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
8.3K
Viral Replication: Lytic Cycle01:20

Viral Replication: Lytic Cycle

Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
2.6K